Oral lipid prodrug V2043 (1-<i>O</i>-octadecyl-2-<i>O</i>-benzyl-<i>sn</i>-glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection. [PDF]
Clark AE +12 more
europepmc +1 more source
Keggin-Type Polyoxometalates as a Systematic Antiviral Scaffold: Activity, Cytotoxicity, and Solution Stability across Heteroion and Addenda Metal Variations. [PDF]
Füllborn-Ott J +4 more
europepmc +1 more source
Remdesivir and All-Cause Graft Loss Among Kidney Transplant Recipients With Symptomatic COVID-19.
Srisurapanont K +12 more
europepmc +1 more source
Electrophysiological and Molecular Features of Remdesivir-Induced Cardiac Toxicity in Male and Female Guinea Pigs. [PDF]
Zhu C, Fu K, Wen H, Chen G, Zhang H.
europepmc +1 more source
Body mass index and baricitinib treatment effect in hospitalized adults with COVID-19: A secondary analysis of ACTT-2. [PDF]
Rigsby R, Gaulton TG.
europepmc +1 more source
Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers. [PDF]
Loubet P +7 more
europepmc +1 more source
Management of patients hospitalized for SARS-CoV-2 infection: A real-world economic evaluation from the hospital perspective. [PDF]
Kalil AC +6 more
europepmc +1 more source
Cardiovascular Risks of COVID-19 Therapeutics: Integrated Analysis of FAERS, Electronic Health Records, and Transcriptomics. [PDF]
Zhu X +8 more
europepmc +1 more source
Remdesivir for the treatment of children hospitalized with COVID-19: a systematic review and meta-analysis. [PDF]
Mahmoudi S, Mohammadpour M, Olfat M.
europepmc +1 more source
Bundibugyo virus-perspectives for the current outbreak. [PDF]
Hoenen T.
europepmc +1 more source

